Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
GlaxoSmithKline
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Documented HIV-1 infection with screening viral load between 5000 and 300,000 copies/mL.
Baseline CD4 cell count greater than 100.
Females must be of non-childbearing potential
Not have received antiretroviral therapy in the 12 weeks prior to first dose.
You may not be if
Must not be infected with hepatitis B or C.
Patients must not have any acute laboratory abnormality.
Must not have any active CDC (Centers for Disease Control and Prevention)Category C disease (1993), except cutaneous Kaposi's sarcoma not requiring systemic therapy during the trial.
Clareo Health | Monotherapy Versus Placebo Over 10 Days in Integrase Naive HIV-1 Infected Adults
